number
divers
infecti
agent
caus
diseas
present
similar
sign
symptom
characterist
infecti
syndrom
classic
set
apart
clinic
infecti
condit
caus
easili
identifi
organ
small
number
relat
organ
eg
typhoid
fever
syndrom
may
bacteri
viral
etiolog
diseas
infecti
etiolog
includ
common
infecti
diseas
dengu
fever
increasingli
present
protean
manifest
atyp
manifest
present
paradigm
shift
occur
clinician
approach
patient
acut
febril
ill
syndrom
approach
clinician
recogn
multipl
differ
infecti
agent
could
potenti
caus
diseas
success
treatment
patient
requir
identif
specif
caus
agent
therefor
reli
laboratori
diagnost
packag
provid
specif
syndrom
mani
descript
syndrom
base
isol
pathogen
andor
serolog
diagnosi
inform
etiolog
enhanc
understand
pathogenesi
epidemiolog
syndrom
method
employ
cumbersom
slow
present
approach
develop
singl
technolog
platform
base
diagnosi
distinct
infecti
syndrom
rapid
turnaround
time
hour
develop
molecular
detect
facilit
approach
use
pcr
modif
dna
microarray
nanotechnolog
use
multiplex
pcr
mpcr
dna
microarray
alreadi
begun
move
research
arena
clinic
servic
laboratori
howev
nanotechnolog
still
emerg
field
excit
potenti
diagnosi
infecti
diseas
nanomateri
versatil
engin
biofunction
particl
field
pathogen
detect
begun
exploit
uniqu
optic
magnet
properti
nanoscal
materi
fluoresc
nanoparticl
metal
nanostructur
superparamagnet
nanoparticl
bioimag
detect
infecti
microorgan
articl
list
import
wide
recogn
entiti
infecti
syndrom
review
recent
literatur
regard
molecular
nanotechnologybas
method
use
diagnosi
literatur
search
topic
reveal
pauciti
specif
inform
would
give
insight
syndrom
infecti
origin
research
laboratori
biotechnolog
compani
tri
develop
use
devic
infecti
syndrom
avail
literatur
certain
limit
geograph
point
view
research
develop
platform
comprehens
diagnosi
import
syndrom
region
review
show
lacuna
research
tropic
countri
must
address
develop
appropri
platform
relev
region
use
hospit
public
health
laboratori
date
research
focus
gener
genom
inform
directli
sampl
tissu
blood
certain
instanc
gener
inform
genotyp
infecti
agent
could
help
formul
treatment
illustr
exampl
treatment
hepat
c
viru
hcv
infect
durat
pegyl
interferon
peginterferon
therapi
determin
genotyp
viral
strain
infect
patient
certain
postamplif
method
includ
sanger
sequenc
pyro
sequenc
target
gene
revers
hybrid
luminex
analysi
come
use
western
countri
survey
publish
literatur
index
pubm
reveal
use
five
differ
molecular
assay
technolog
recent
develop
detect
variou
microbialvir
infect
principl
intend
use
assay
discuss
review
term
exanthem
refer
rash
skin
occur
gener
children
rash
spread
bodi
may
caus
microorgan
virus
infecti
caus
howev
note
develop
clinic
condit
may
also
due
exposur
toxin
drug
result
autoimmun
diseas
noninfecti
caus
infecti
etiolog
includ
measl
viru
rubella
viru
varicella
zoster
viru
vzv
parvoviru
human
herpesviru
hhv
epsteinbarr
viru
ebv
enterovirus
dengu
viru
bacteri
infect
scarlet
fever
staphylococcu
aureu
infect
toxic
shock
syndrom
meningococcemia
typhoid
fever
rickettsi
infect
may
also
present
fever
exanthema
research
veterinari
diagnost
made
progress
establish
definit
diagnosi
vesicular
vesicularlik
lesion
livestock
anim
difficult
achiev
differenti
etiolog
diagnosi
footandmouth
diseas
viru
fmdv
vesicular
stomat
viru
vsv
swine
vesicular
diseas
viru
svdv
rapid
method
describ
use
padlock
probe
microarray
detect
simultan
differenti
three
virus
singl
reaction
padlock
probemicroarray
assay
assay
lower
limit
detect
median
tissu
cultur
infect
dose
per
assay
fmdv
per
assay
vsv
per
assay
svdv
although
method
evalu
clinic
sampl
author
conclud
compar
realtim
pcr
likewis
highthroughput
multiplex
assay
develop
laboratori
use
detect
differenti
fmdv
similar
diseasecaus
virus
assay
simultan
screen
five
rna
two
dna
virus
use
multiplex
reversetranscript
pcr
mrtpcr
amplif
coupl
microspher
hybrid
array
flowcytometr
detect
sensit
mrtpcr
fmdv
specif
evalu
perform
panel
clinic
confirm
posit
neg
case
interest
studi
describ
applic
long
oligonucleotid
microarray
assay
identif
virus
known
caus
vesicular
vesicularlik
lesion
livestock
anim
result
suggest
microarray
assay
could
valuabl
tool
diagnosi
vesicular
vesicularlik
diseas
assay
use
epithelium
sampl
vesicular
lesion
author
report
difficulti
templat
prepar
furthermor
assay
vari
sensit
differ
virus
valid
probe
set
optim
sampl
prepar
procedur
need
opinion
would
use
diagnost
devic
could
correctli
identifi
etiolog
import
fever
rash
measl
rubella
parvoviru
rickettsi
rash
scarletin
rash
human
central
nervou
system
cn
infect
acut
life
threaten
warrant
immedi
diagnosi
enabl
specif
antimicrobialantivir
therapi
etiolog
bacteri
mening
consist
streptococcu
pneumonia
haemophilu
influenza
type
b
neisseria
meningitidi
listeria
monocytogen
sever
viral
agent
caus
asept
mening
includ
member
genu
enteroviru
herp
simplex
viru
hsv
mump
viru
enceph
acut
inflamm
white
matter
brain
enceph
mening
inflamm
mening
known
meningoenceph
symptom
includ
headach
fever
confus
drowsi
fatigu
sever
symptom
includ
seizuresconvuls
tremor
hallucin
memori
problem
viral
enceph
may
sporad
epidem
occurr
common
caus
enceph
human
infect
hsv
condit
occur
sporad
part
globe
contrast
viral
enceph
occur
epidem
geograph
restrict
area
depend
vector
distribut
eg
japanes
enceph
occur
south
southeast
asia
enceph
also
caus
bacteri
infect
bacteri
mening
spread
directli
brain
primari
enceph
may
complic
current
infecti
diseas
syphili
secondari
enceph
certain
parasit
protozo
infest
toxoplasmosi
malaria
primari
amoeb
meningoenceph
also
caus
enceph
peopl
compromis
immun
system
lyme
diseas
andor
bartonella
hensela
may
also
caus
enceph
boriskin
et
al
develop
microarraybas
viru
detect
assay
viral
agent
caus
mening
enceph
target
target
gene
clinic
sensit
specif
assay
establish
respect
result
compar
uniplex
pcr
consid
gold
standard
author
investig
varieti
dna
rna
neurotrop
virus
includ
member
herpesvirida
picornavirida
famili
util
assay
limit
viru
specif
strainspecif
variat
detect
could
limit
rna
virus
genet
variat
nucleotid
polymorph
among
rna
viru
strain
antemortem
diagnosi
infecti
meningoenceph
affect
human
molecular
test
gain
signific
currenc
modif
pcr
use
consensu
degener
hybrid
primer
codehop
use
identifi
character
novel
infecti
agent
molecular
test
also
gain
accept
veterinari
infecti
diseas
diagnosi
test
convent
realtim
pcr
shown
use
diagnosi
cn
infect
caus
agent
canin
distemp
viru
toxoplasma
gondii
neospora
caninum
rickettsi
speci
other
codehop
approach
use
canin
meningoenceph
includ
assay
rickettsi
organ
borrelia
spp
bartonella
spp
viral
famili
must
emphas
though
report
innov
need
thorough
evalu
clinic
set
test
could
accept
gold
standard
zheng
et
al
develop
mpcrbase
dna
microarray
simultan
detect
well
speci
identif
seven
human
herp
virus
name
vzv
ebv
cytomegaloviru
cmv
primer
oligonucleotid
probe
target
highli
conserv
region
dna
polymeras
gene
human
herp
virus
dna
microarray
made
print
oligonucleotid
probe
onto
special
glass
slide
amplif
label
pcr
product
hybrid
microarray
chip
techniqu
compar
taqman
probebas
realtim
pcr
microarray
lower
limit
detect
show
crossreact
evalu
perform
clinic
cerebrospin
fluid
csf
sampl
children
assay
sensit
specif
figur
show
principl
pcrbase
dna
microarray
landmark
develop
diagnosi
neurolog
infect
shi
et
al
report
evalu
pcr
microarray
could
detect
seven
virus
name
vzv
ebv
cmv
mpcr
product
genotyp
dna
microarray
technolog
multiplex
primer
oligonucleotid
probe
specif
highli
conserv
region
dna
polymeras
gene
assay
show
nonspecif
like
assay
develop
zheng
et
al
assay
develop
shi
et
al
lower
limit
detect
copi
viral
load
author
test
csf
sampl
children
report
sensit
specif
similar
result
report
zheng
et
al
studi
gaeta
et
al
report
quantit
realtim
pcr
assay
detect
six
virus
caus
mening
meningoenceph
csf
sampl
assay
abl
detect
ebv
cmv
vzv
correl
clinic
condit
herp
viral
coinfect
document
sever
patient
lower
limit
detect
genom
copiesml
copi
per
reaction
diagnost
sensit
rang
differ
virus
test
would
accept
use
clinic
laboratori
rapid
quantit
realtim
reversetranscript
loopmedi
isotherm
amplif
rtlamp
assay
develop
detect
japanes
enceph
viru
jev
target
envelop
gene
lower
limit
detect
less
plaqueform
unit
pfu
assay
specif
jev
fals
detect
flavivirus
dengu
viru
west
nile
viru
wnv
clinic
evalu
test
essenti
decis
made
use
figur
show
principl
lamp
assay
sinc
cn
infect
life
threaten
attempt
made
develop
assay
system
suitabl
comprehens
etiolog
diagnosi
would
facilit
prompt
initi
appropri
therapi
measur
would
life
save
larg
extent
would
prevent
neurolog
sequela
sexual
transmit
infect
sti
infect
genitourinari
tract
spread
vener
transmiss
affect
wide
age
group
older
teenag
older
adult
preval
increas
sti
constitut
infecti
syndrom
caus
multipl
agent
includ
bacteria
virus
parasit
sever
infecti
clinic
identifi
male
femal
infect
may
asymptomat
sever
sti
affect
fertil
especi
among
femal
eg
pelvic
inflammatori
diseas
consequ
chlamydi
infect
group
infect
consid
high
prioriti
develop
accur
easi
pandiagnost
devic
detail
laboratori
investig
aid
specif
diagnosi
sex
commerci
close
system
coba
ctng
test
success
use
highthroughput
identif
chlamydia
trachomati
neisseria
gonorrhoea
infect
assay
use
urin
sampl
show
sensit
specif
neg
predict
valu
posit
predict
valu
c
trachomati
correspond
valu
respect
n
gonorrhoea
urethralcerv
swab
specimen
sensit
specif
neg
predict
valu
posit
predict
valu
respect
c
trachomati
respect
n
gonorrhoea
clear
import
bloodborn
virus
human
immunodefici
viru
hiv
hepat
b
viru
hbv
hcv
effici
transmit
sexual
rout
thu
assay
detect
virus
could
use
screen
blood
blood
product
patient
attend
sti
clinic
method
develop
base
realtim
mrtpcr
perform
within
microarray
hydrogel
pad
assay
doublestrand
amplif
product
simultan
detect
use
nonspecif
sybr
green
dye
test
separ
pad
bear
specif
primer
evalu
refer
strain
store
plasma
sampl
lower
limit
detect
rang
genom
equival
per
reaction
assay
three
virus
test
sensit
specif
establish
global
human
papillomaviru
hpv
import
sti
agent
multipl
genotyp
viru
caus
genit
wart
certain
type
known
involv
etiolog
cervic
cancer
earli
diagnosi
infect
viru
therefor
import
dna
microarray
chip
assay
base
lightscatt
aggreg
silica
nanoparticl
probe
develop
target
hpv
dna
sandwich
captur
dna
immobil
chip
probe
dna
immobil
plain
silica
nanoparticl
spot
sandwich
reaction
occur
appear
bright
white
readili
distinguish
nake
eye
visual
detect
effici
use
nm
silica
nanoparticl
pm
target
dna
author
demonstr
develop
portabl
nanodevic
detect
genotyp
hpv
lower
limit
detect
pm
simpl
microscop
illumin
system
pm
nm
nake
eye
advantag
includ
low
cost
lightscatt
detector
system
abil
use
system
without
devic
nakedey
examin
also
plain
silica
particl
readili
avail
de
et
al
develop
line
probe
assay
detect
genotyp
hpv
dna
abnorm
papanicolaoustain
cervicovagin
smear
method
report
effici
sensit
fast
use
routin
investig
better
clinic
manag
patient
point
potenti
applic
line
probe
assay
suffici
exploit
figur
illustr
principl
assay
previous
tang
et
al
develop
visual
gene
detect
techniqu
high
sensit
specif
clinic
applic
visual
dna
microarray
capabl
simultan
sensit
specif
detect
treponema
pallidum
assay
use
gold
label
silver
stain
glss
coupl
asymmetr
mpcr
method
aminomodifi
oligonucleotid
immobil
glass
surfac
use
captur
probe
bind
complementari
biotinyl
target
dna
goldconjug
streptavidin
use
microarray
specif
bind
biotin
microarray
spot
develop
black
result
precipit
silver
onto
nanogold
particl
bound
streptavidin
pcr
product
pallidum
use
posit
control
result
compar
realtim
pcr
find
lower
limit
detect
assay
copiesml
target
dna
amplicon
prepar
convent
pcr
mpcr
copiesml
prepar
asymmetr
pcr
asymmetr
mpcr
subsequ
tang
et
al
develop
glssdepend
visual
protein
microarray
techniqu
simultan
sensit
specif
detect
ureaplasma
parvum
chlamydia
trachomati
author
use
nterminu
multipleband
antigen
u
parvum
major
outer
membran
protein
c
trachomati
assay
specif
antigen
label
nanogoldstaphylococc
protein
spa
immobil
glass
surfac
treat
bound
antigen
recogn
complementari
target
antibodi
appli
prepar
microarray
surfac
assay
util
sandwich
format
wherein
nanogoldspa
probe
use
indic
glss
appli
amplifi
detect
signal
produc
black
imag
array
spot
visibl
nake
eye
lower
limit
detect
protein
microarray
assay
ngml
sensit
compar
fluoresc
detect
method
result
found
consist
elisa
quantit
realtim
pcr
assay
clinic
sampl
current
literatur
document
sever
success
attempt
develop
diagnost
tool
aid
diagnosi
sti
syndrom
assay
requir
evalu
variou
laboratori
field
test
wide
use
major
hemorrhag
fever
caus
virus
often
term
viral
hemorrhag
fever
vhf
refer
group
ill
caus
sever
distinct
famili
virus
gener
term
vhf
use
describ
sever
multisystem
syndrom
ie
multipl
organ
system
bodi
affect
characterist
overal
vascular
system
damag
bodi
abil
regul
impair
symptom
often
accompani
hemorrhag
bleed
howev
bleed
rare
life
threaten
agent
vhf
envelop
rna
virus
surviv
depend
anim
insect
host
call
natur
reservoir
virus
geograph
restrict
area
host
speci
live
human
natur
reservoir
virus
human
infect
come
contact
infect
host
howev
virus
accident
transmiss
host
human
transmit
viru
one
anoth
human
case
outbreak
hemorrhag
fever
caus
virus
occur
sporad
irregularli
occurr
outbreak
easili
predict
noteworthi
except
cure
establish
drug
treatment
vhf
diseas
similar
clinic
symptom
specif
laboratori
diagnost
test
necessari
provid
differenti
diagnosi
especi
outbreak
specif
diagnosi
would
help
public
health
offici
institut
appropri
measur
control
outbreak
vhf
caus
four
distinct
famili
rna
virus
arenavirida
lassa
junin
machupo
sabia
guanarito
filovirida
ebola
marburg
bunyavirida
hantaviru
flavivirida
dengu
viru
kyasanur
forest
diseas
viru
type
vhf
character
fever
along
bleed
disord
progress
high
fever
shock
death
extrem
case
vhf
agent
caus
rel
mild
ill
scandinavian
nephropathia
epidemica
other
african
ebola
viru
caus
sever
lifethreaten
diseas
dengu
viru
caus
ill
rang
classic
dengu
fever
febril
ill
dengu
hemorrhag
fever
dengu
shock
syndrom
dengu
viru
four
distinct
serotyp
potenti
caus
clinic
diseas
maneekan
et
al
develop
singletub
mrtpcr
primer
target
nonstructur
protein
region
dengu
viru
genom
highli
conserv
region
dengu
viru
serotyp
author
compar
new
assay
well
establish
convent
pcr
mrtpcr
assay
sensit
specif
lower
limit
detect
rang
pfu
per
assay
reaction
differ
serotyp
test
trombley
et
al
design
taqmanbas
realtim
pcr
assay
specif
absolut
quantit
detect
multipl
hemorrhag
fever
virus
author
evalu
format
found
viru
specif
limit
detect
assay
rang
pfu
per
assay
reaction
assay
provid
qualit
quantit
data
clinic
evalu
assay
await
figur
depict
taqman
principlebas
realtim
pcr
recogn
infect
emerg
diseas
threat
public
health
profession
benefit
laboratori
abl
provid
syndrom
diagnosi
initi
toward
goal
progress
hepat
character
presenc
inflammatori
cell
liver
tissu
condit
selflimit
heal
progress
fibrosi
scar
cirrhosi
hepat
may
occur
limit
symptom
often
lead
jaundic
anorexia
poor
appetit
malais
hepat
consid
acut
last
less
month
chronic
persist
longer
group
virus
known
hepat
virus
caus
case
hepat
worldwid
hepat
also
due
toxin
notabl
alcohol
certain
medic
plant
infect
autoimmun
diseas
acut
hepat
caus
hepat
viru
hav
hbv
hcv
hepat
viru
hdv
hepat
e
viru
hev
hsv
cmv
ebv
yellow
fever
viru
adenovirus
nonvir
infect
gondii
leptospira
speci
coxiella
burnetii
hbv
without
superinfect
hdv
hcv
import
agent
bloodborn
transmiss
nucleic
acid
test
platform
detect
hiv
hbv
hcv
includ
branch
dna
assay
realtim
mpcr
assay
use
blood
bank
blood
product
test
virus
either
difficult
danger
cultur
molecular
method
becom
gold
standard
tang
et
al
develop
novel
assay
base
electrochem
immunosensor
array
simultan
detect
hepat
viru
antigen
ie
hav
hbv
hcv
hdv
hev
hepat
viru
antibodi
immobil
electrochem
sensor
array
use
nanogold
particl
protein
individu
matric
immunosensor
array
use
captur
correspond
antigen
sampl
solut
onestep
captur
format
analyt
detect
depend
electr
potenti
chang
nativ
state
analytebound
state
use
twoelectrod
system
five
type
hepat
viru
antigen
identifi
immunosensor
assay
within
minut
detect
limit
ngml
moreov
assay
show
crossreact
nonspecif
bind
chipbas
immunosensor
array
open
new
opportun
highthroughput
multianalyt
immunoassay
simpl
nanodevic
physician
could
use
point
care
jothikumar
et
al
develop
realtim
rtpcr
assay
quantit
detect
hav
coxsackieviru
environment
sampl
extract
rna
compat
quantit
rtpcr
detect
sensit
pfu
per
reaction
basi
result
author
conclud
develop
assay
could
applic
detect
pathogen
water
food
wang
et
al
report
quantum
dot
qd
dna
nanosensor
base
fluoresc
reson
energi
transfer
fret
detect
dna
singl
mismatch
hbv
genom
examin
synthet
oligonucleotid
contain
mutat
revers
transcriptas
rt
gene
indic
resist
lamuvidin
use
treatment
hbv
infect
studi
use
watersolubl
cadmium
selenidezinc
sulfid
qd
acid
subsequ
oligonucleotid
attach
qd
surfac
form
function
qddna
conjug
sandwich
hybrid
form
addit
dna
target
signal
dna
qddna
conjug
result
assembl
allow
fluorophor
acceptor
qd
donor
brought
proxim
result
fluoresc
emiss
acceptor
mean
fret
follow
illumin
donor
author
use
oligonucleotid
ligat
assay
detect
singlebas
mutant
hbv
genom
show
singlebas
mismatch
recogn
ligas
henc
detect
probe
ligat
emiss
produc
lack
fret
qddna
fretbas
nanosensor
assay
lower
limit
detect
nm
advantag
techniqu
includ
simplic
effici
use
multilabel
plate
assay
detect
singlebas
mutant
target
dna
use
multicolor
dye
rather
use
fluorimet
fluorometr
method
complic
time
consum
detect
character
signal
qddna
fret
system
method
simpl
effici
could
potenti
use
highthroughput
multiplex
detect
target
dna
mutant
figur
show
principl
qd
hepat
differ
viral
etiolog
occur
differ
part
globe
situat
waterborn
epidem
hav
hev
iatrogen
situat
hbv
hcv
practic
physician
benefit
inform
specif
etiolog
appropri
manag
specif
antivir
therapi
quantit
assay
base
realtim
pcr
give
valuabl
inform
help
monitor
treatment
diarrheal
diseas
affect
age
group
occur
mani
part
world
especi
develop
countri
children
particularli
affect
die
diseas
ill
occur
epidem
via
either
waterborn
foodborn
rout
etiolog
bacteri
viral
protozoan
earli
etiolog
diagnosi
could
allow
prevent
public
health
measur
appropri
therapi
enterotoxigen
escherichia
coli
etec
common
pathogen
worldwid
caus
infecti
diarrhea
especi
travel
diarrhea
convent
organ
character
physiolog
assay
immunoassay
pcrbase
method
detect
etec
heatlabil
enterotoxin
andor
heatstabl
enterotoxin
separ
serotyp
method
use
antisera
requir
determin
etec
serogroup
wang
et
al
develop
dna
microarray
could
simultan
detect
enterotoxin
gene
common
oserogroup
gene
etec
strain
random
pcr
strategi
use
author
document
effect
altern
mpcr
detect
pathogen
use
dna
microarray
et
al
develop
microarray
techniqu
detect
identif
enteropathogen
bacteria
speci
subspeci
level
stool
specimen
pathogen
target
e
coli
vibrio
cholera
vibrio
parahaemolyticu
salmonella
enterica
campylobact
jejuni
shigella
yersinia
enterocolitica
target
label
fluoresc
dye
mpcr
hybrid
specif
virul
gene
probe
immobil
microchip
dna
microarray
detect
pathogen
concentr
low
genom
find
compar
confirm
speciesspecif
convent
pcr
nest
pcr
sequenc
techniqu
appear
attract
diagnost
tool
rapid
simultan
identif
multipl
enteropathogen
pathogen
clinic
practic
especi
patient
infecti
diarrhea
combin
mpcr
dna
microarray
tyramid
signal
amplif
develop
jin
et
al
simultan
detect
six
human
diarrheal
pathogen
name
yersinia
enterocolitica
shigella
spp
salmonella
typhi
v
cholera
e
coli
brucella
spp
method
also
distinguish
v
cholera
serotyp
serotyp
e
coli
assay
found
specif
diagnost
detect
surveil
multipl
human
pathogen
detect
limit
colonyform
unit
cfu
ml
sensit
dna
microarray
base
cutoff
valu
hybrid
signal
mpcr
assay
develop
morin
et
al
simultan
detect
e
coli
v
cholera
typhi
target
specif
uniqu
region
assay
found
detect
cell
e
coli
typhi
clinic
isol
assay
need
test
clinic
sampl
test
isol
li
et
al
develop
dna
microarray
target
oserotypespecif
gene
detect
ten
serotyp
shigella
shigella
sonnei
shigella
flexneri
type
shigella
boydii
type
shigella
dysenteria
type
five
serotyp
e
coli
detect
sensit
ng
genom
dna
cfuml
mock
stool
specimen
result
suggest
assay
could
use
clinic
diagnosi
food
safeti
epidemiolog
surveil
diarrheal
diseas
especi
caus
diarrheagen
e
coli
certain
virus
rotaviru
noroviru
similar
virus
today
recogn
global
problem
problem
sever
poor
develop
countri
tropic
region
specif
etiolog
inform
import
public
health
profession
implement
prevent
measur
assay
use
dnamicroarray
realtim
mpcr
platform
would
advantag
ophthalm
infect
includ
infect
conjunctiva
conjunct
cornea
kerat
cornea
conjunctiva
keratoconjunct
interior
eye
endopthalm
condit
caus
differ
agent
includ
bacteria
virus
fungi
viral
infect
tend
occur
epidem
bacteri
infect
occur
small
outbreak
et
al
evalu
quantit
realtim
pcr
detect
corneal
swab
import
caus
agent
ophthalm
infect
kerat
keratouv
rt
kit
vitro
medic
diagnost
devic
intend
use
appli
biosystem
real
time
instrument
appli
biosystem
foster
citi
ca
usa
kit
allow
absolut
quantit
analysi
pcr
product
use
elidna
qrt
standard
elisabeth
pharmacon
pragu
czech
republ
detect
limit
describ
kit
genom
copi
per
reaction
result
correl
clinic
pictur
diseas
offer
exact
identif
viral
dna
patient
herp
stromal
kerat
studi
carri
use
quantit
realtim
pcr
detect
cmv
patient
epitheli
stromal
endotheli
kerat
unknown
origin
author
investig
differ
type
sampl
includ
tear
corneal
scrape
aqueou
humor
specimen
studi
document
util
quantit
pcr
assay
diagnosi
monitor
clinic
cours
diseas
sinc
infect
eye
potenti
caus
vision
loss
earli
diagnosi
treatment
import
vari
etiolog
dna
microarray
approach
may
hold
key
congenit
infect
infect
like
affect
fetu
utero
mother
activ
infect
classic
known
torch
agent
refer
infect
gondii
rubella
viru
cmv
hsv
develop
countri
medic
expert
extend
acronym
torch
includ
syphili
caus
pallidum
list
may
also
extend
includ
less
common
agent
condit
vzv
hbv
hiv
hiv
infect
matern
transmiss
infect
mother
newborn
occur
mainli
child
birth
molecular
test
hiv
either
provir
dna
rna
target
blood
plasma
respect
altern
hiv
antigen
test
determin
infect
infant
use
heat
plasma
serum
sampl
earli
diagnosi
level
antigen
report
significantli
higher
transmit
mother
nontransmit
mother
earli
diagnosi
matern
infect
bear
fetal
health
develop
newborn
great
import
obstetrician
perinatalogist
sever
infect
recogn
categori
import
develop
success
diagnosi
multipl
etiolog
exampl
recent
work
toward
common
molecular
method
diagnosi
torch
group
infect
led
develop
qdbase
protein
microarray
simultan
detect
torchrel
antibodi
sera
techniqu
combin
principl
immunofiltr
qdlabel
probe
detect
newli
develop
assay
compar
standard
elisa
method
found
give
statist
similar
result
quicker
turnaround
time
thu
offer
rapid
diagnost
tool
develop
commerci
assay
investig
repres
great
stride
forward
infecti
diseas
diagnost
review
use
term
febril
ill
refer
communic
exogen
infect
present
pyrexia
short
durat
week
acut
febril
ill
would
includ
certain
viral
bacteri
infect
dengu
fever
typhoid
fever
may
distinguish
featur
enabl
physician
make
provision
diagnosi
eg
dengu
fever
character
sever
myalgia
retroorbit
pain
wherea
typhoid
fever
usual
present
prodrom
gastrointestin
symptom
categori
pyrexia
unknown
origin
puo
often
patient
treat
empir
specif
diagnosi
would
obvious
help
determin
appropri
use
antimicrobi
support
therapi
classic
definit
puo
fever
least
week
durat
caus
remain
undiagnos
even
detail
investig
gener
puo
caus
bacteri
viral
agent
includ
improperli
investig
typhoid
fever
melioidosi
tuberculosi
q
fever
earli
hiv
infect
hbv
infect
ebv
infect
salmonella
spp
import
caus
agent
foodborn
diseas
lowdens
dnamicroarray
contain
oligonucleotid
probe
develop
detect
wide
rang
specif
marker
gene
associ
antibiot
resist
cell
envelop
structur
mobil
genet
element
pathogen
group
organ
recent
publish
studi
indic
dna
microarray
assay
may
suitabl
use
monitor
food
safeti
measur
implement
develop
countri
includ
us
rapid
sensit
microarray
design
detect
chikungunya
viru
jev
yellow
fever
viru
dengu
viru
hantaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
avian
influenza
viru
patient
puo
panel
includ
nine
genera
viru
speci
consensu
genusspecif
primer
use
revers
transcrib
viral
target
gene
minim
interfer
virus
oligonucleotid
use
genu
level
oligonucleotid
use
speci
level
secondstrand
synthesi
carri
random
primer
amplifi
product
label
process
microarray
analys
agre
author
state
assay
could
potenti
use
clinic
diagnosi
onestep
singl
tube
realtim
rtlamp
assay
develop
evalu
standard
strain
clinic
specimen
spike
differ
concentr
viru
strain
detect
envelop
gene
wnv
specif
rtlamp
assay
valid
absenc
crossreact
close
relat
member
flaviviru
group
result
indic
rtlamp
assay
extrem
rapid
cost
effect
highli
sensit
detect
limit
pfu
viru
potenti
use
rapid
comprehens
wnv
surveil
along
viru
isol
andor
serolog
group
develop
dengu
viru
serotypespecif
rtlamp
assay
clinic
isol
serum
sampl
confirm
case
cross
react
wnv
jev
rtlamp
assay
show
sensit
pfu
viru
sensit
rtpcr
patient
serum
sampl
refer
result
viru
isol
assay
sensit
specif
respiratori
infect
caus
varieti
microbi
viral
agent
import
opportunist
infect
communic
agent
caus
infect
commun
acquir
may
caus
lower
respiratori
tract
infect
lrti
upper
respiratori
tract
infect
urti
lrti
seriou
may
caus
pneumonia
virus
respiratori
syncyti
viru
rsv
caus
seriou
lrti
young
children
sever
part
globe
recent
year
two
import
global
concern
avian
influenza
pandem
swine
influenza
studi
agraw
et
al
demonstr
use
antibodyconjug
nanoparticl
rapid
sensit
quantit
detect
rsv
studi
dualcolor
qd
fret
nanobead
use
viru
detect
nanoparticl
character
sensit
specif
cell
cultur
lysat
differ
virus
assay
need
evalu
clinic
sampl
wang
et
al
develop
evalu
novel
mpcrbase
revers
line
blot
assay
simultan
detect
potenti
respiratori
pathogen
children
communityacquir
pneumonia
pathogen
includ
aureu
pneumonia
streptococcu
pyogen
moraxella
catarrhali
h
influenza
h
influenza
type
b
bordetella
pertussi
klebsiella
pneumonia
legionella
pneumophila
mycobacterium
tuberculosi
chlamydia
pneumonia
mycoplasma
pneumonia
pneumonia
h
influenza
includ
type
b
import
pathogen
detect
multipl
pathogen
two
detect
specimen
studi
show
assay
sensit
tool
identif
respiratori
pathogen
recent
develop
use
dnamicroarray
platform
technolog
virochip
detect
virus
caus
pediatr
respiratori
tract
infect
virochip
compar
convent
direct
fluoresc
antibodi
dfa
pcrbase
test
detect
respiratori
virus
nasopharyng
aspir
sampl
virochip
show
sensit
specif
rsv
influenza
rhinovirusesenterovirus
test
show
greater
detect
dfa
interestingli
virochip
abl
detect
mix
infect
well
unlik
dfa
pcr
import
studi
acut
lrti
costeffect
mpcr
assay
use
nasopharyng
aspir
report
detect
rsv
influenza
virus
parainfluenza
virus
human
metapneumoviru
mpcr
assay
detect
respiratori
virus
sampl
studi
young
children
show
predomin
rsv
mix
viral
infect
detect
children
use
recent
introduc
rtlamp
assay
report
highli
pathogen
avian
influenza
viru
infect
author
report
higher
sensit
assay
compar
onestep
rtpcr
assay
highli
specif
subtyp
develop
platform
agent
caus
lrti
excit
improv
field
molecular
diagnosi
respiratori
infect
term
opportunist
infect
refer
group
infect
caus
diseas
enceph
lymphaden
primarili
secondarili
immunocompromis
patient
eg
hivinfect
individu
transplant
recipi
opportunist
infect
caus
virus
bacteria
protozoa
fungi
number
agent
larg
pathogenspecif
diagnosi
avail
vast
major
assay
avail
design
identifi
pathogen
caus
enceph
immunocompromis
patient
exampl
realtim
pcr
assay
dna
neurotrop
virus
use
pcrbase
lowdens
dna
microarray
report
pathogen
known
caus
granulomat
lymphaden
assay
use
dna
extract
paraffinembed
tissu
mpcr
amplicon
hybrid
glass
slide
contain
probe
mycobacterium
spp
yersinia
spp
bartonella
henselea
gondii
studi
found
techniqu
use
make
specif
diagnosi
though
would
benefit
inclus
broader
rang
probe
sequenc
addit
speciesspecif
assay
number
immunosuppress
patient
grow
worldwid
result
widespread
increas
transplant
program
differ
part
globe
well
stillsmold
hiv
pandem
consequ
frequenc
opportunist
infect
also
increas
present
sever
platform
base
realtim
mpcr
dna
microarray
import
viral
infect
especi
herp
group
discuss
section
data
avail
differ
area
globe
indic
similar
etiolog
certain
infecti
condit
agent
latent
individu
caus
endogen
infect
opportunist
infect
among
immunosuppress
individu
mani
infect
communic
ie
transmiss
member
commun
except
special
set
howev
vast
major
infect
communic
exogen
pose
public
health
threat
abil
caus
outbreak
epidem
infect
communic
diseas
may
spread
global
eg
avian
flu
pandem
influenza
swine
flu
wherea
infecti
syndrom
vhf
acut
febril
ill
occur
geograph
restrict
area
etiolog
sever
syndrom
studi
region
region
identifi
individu
pathogen
agent
given
syndrom
individu
agent
caus
geograph
preval
syndrom
vari
host
environment
factor
eg
poor
sanit
unsaf
water
vector
vector
arthropod
anim
carrier
zoonot
host
differ
differ
geograph
area
thu
etiolog
infecti
syndrom
differ
north
south
america
africa
asia
distinctli
temper
tropic
climat
exampl
import
caus
febril
ill
india
typhi
caus
typhoid
fever
wherea
far
east
frequent
caus
febril
ill
burkholderia
pseudomallei
caus
melioidosi
context
geograph
variat
pathogen
diseas
manifest
one
could
cite
exampl
hantavirus
wide
distribut
rodentborn
virus
group
virus
caus
two
import
syndrom
hemorrhag
fever
renal
syndrom
hfr
eurasia
hantaviru
pulmonari
syndrom
america
hfr
clinic
distinct
febril
ill
character
hemorrhag
rash
renal
dysfunct
seoul
viru
hantaviru
transmit
domest
rat
rattu
rattu
global
distribut
movement
rat
new
area
intern
ship
diseas
caus
seoul
viru
infect
hfr
therefor
occur
around
globe
sin
nombr
viru
new
world
hantavirus
transmit
rodent
subfamili
sigmodontina
new
world
rat
deer
mice
caus
hantaviru
cardiac
pulmonari
syndrom
hcp
america
and
viru
transmit
longtail
pygmi
rice
rat
caus
sever
form
hcp
south
america
henc
geograph
regionspecif
data
vital
design
laboratori
diagnost
tool
anoth
outstand
exampl
geograph
variat
absenc
yellow
fever
viru
transmit
mosquito
aed
aegyptii
india
vector
involv
transmiss
dengu
viru
yellow
fever
viru
south
america
wherea
india
speci
mosquito
involv
transmiss
dengu
viru
certain
flavivirus
common
south
america
interestingli
certain
infecti
agent
seen
geograph
circumscrib
area
exampl
kyasunur
forest
diseas
transmit
hemophag
tick
seen
shimoga
district
karnataka
india
similarli
bartonella
bacilliformi
transmit
sandfli
genu
lutzomyia
caus
oroya
fever
seen
south
america
rocki
mountain
spot
fever
often
consid
endem
us
premis
need
epidemiolog
surveil
data
determin
ident
infecti
agent
caus
infecti
syndrom
predomin
region
assay
appropri
syndrom
diagnosi
develop
infecti
diseas
diagnosi
histor
base
clinic
acumen
laboratori
procedur
mediabas
cultur
bacteria
cell
cultur
virus
microscopi
serolog
often
laboratori
investig
focus
establish
pathogen
link
clinic
condit
essenti
hit
miss
approach
approach
consid
expert
highli
ineffici
imper
comprehens
epidemiolog
data
obtain
allow
develop
assay
could
use
given
region
world
global
current
trend
develop
molecular
nanotechnologybas
diagnost
tool
encourag
molecular
techniqu
hold
special
promis
area
pcrbase
dna
microarray
realtim
mpcr
nanotechnologybas
devic
nanoscal
reaction
wherein
analyt
detect
biosensor
